Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

IDIQ - Microbiology of FDA-regulated items

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Food and Drug Administration is forecasting an Indefinite Delivery, Indefinite Quantity contract focused on the microbiology of FDA-regulated items. The scope of work encompasses the analysis of regulated foods, agricultural water, environmental samples, and cosmetics, with a specific technical emphasis on whole genome sequencing. Classified under NAICS code 541714, this procurement is managed by the FDA's Hfp Acquisition Liaison. While specific set-aside details and a formal solicitation number have not yet been established, the opportunity is intended to support the agency's ongoing regulatory and safety monitoring efforts through advanced microbiological testing.

General Info

FDA IDIQ contract for microbiological analysis and whole genome sequencing of regulated items.

Agency

Food and Drug Administration → Food And Drug Administration

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyFood and Drug Administration → Food And Drug Administration

Contacts2 people available

OfficeN/A

Organization / AgencyFood and Drug Administration → Food And Drug Administration

Office AddressN/A

Contacts

Hfp Acquisition Liaison

contact@example.gov

To Be Determined To Be DeterminedContracting Officer

Full Description

Show more

Microbiology of FDA-Regulated Foods, Agricultural Water, Environmental Samples, Cosmetics, and Whole Genome Sequencing

Similar Contracts

Same NAICS industry code

USDA SBIR/STTR Topic 8.2 — Plant Production and Protection - Biology

Solicitation # USDA-NIFA-TOPIC-8.2

The USDA National Institute of Food and Agriculture is soliciting proposals under Topic 8.2 for Plant Production and Protection - Biology. This initiative focuses on advancing crop production and protection through the development of innovative plant breeding methods, diagnostic technologies for diseases, and the creation of new food and non-food crop plants. Research efforts are directed toward improving plant characteristics to mitigate biotic and abiotic stresses, developing new genotypes for commercial applications, and creating tools to support the health of natural and domesticated pollinators. This opportunity is a total small business set-aside under the SBIR/STTR mandate, restricting eligibility to companies with fewer than 500 employees. Managed by the United States Department of Agriculture, the program is led by Dr. Christopher Philips. Interested parties can find further details and application guidelines through the NIFA website.

National Institute of Food and Agriculture

POSTED

about 8 hours ago

DEADLINE

Clinical Trial Management and ExecutionThe Clinical Trial Management and Execution subcontract, issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, focuses on the operational and clinical execution of human subject research for FDA regulatory science projects. The selected provider will be responsible for managing patient recruitment, trial monitoring, and data collection across various clinical sites, ensuring all activities strictly adhere to Good Clinical Practice guidelines and Institutional Review Board approvals. Key deliverables for this engagement include the submission of clinical study reports, comprehensive patient data sets, and detailed trial outcome summaries. Interested parties should note that the response deadline for this opportunity is January 22, 2027, and the work falls under NAICS code 541714.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

Solicitation # FDABAA-27-00123

The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting basic and applied research and development proposals under Broad Agency Announcement FDABAA-27-00123. This initiative seeks to leverage industry and academic capabilities to advance regulatory science and innovation, focusing on improvements in technology, materials, processes, and methods to protect and promote national health. The solicitation is open to all responsible sources, with a strong encouragement for small business participation. Proposals are evaluated based on innovation, soundness and feasibility, technical understanding, and relevance to agency programs, utilizing a peer or scientific review process. Submissions must be unclassified and consist of a Concept Paper, limited to three pages and 2 megabytes, and a Full Proposal divided into a technical volume and a cost volume. The technical proposal is limited to 50 pages, while the cost volume appendices are limited to 20 pages. The deadline for submission is January 22, 2027, at 5:00 PM EST. Awardees must comply with strict quality standards, including Good Manufacturing Practices (GMP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP) where applicable. Additionally, contractors must disclose any organizational conflicts of interest and provide a Small Business Subcontracting Plan for awards exceeding 900,000 dollars.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Biostatistical Analysis for Epidemiological and Experimental StudiesThis subcontract involves providing biostatistical analysis for epidemiological and experimental study datasets on behalf of prime contractors working with the Washington State Department of Labor and Industries. The scope of work includes performing detailed data analysis via encrypted electronic file transfers and delivering comprehensive analysis reports along with formal certification of data disposition. To qualify for this engagement, the contractor must complete the Washington State Institutional Review Board training for the Protection of Human Subjects in Research. The project is categorized under NAICS code 541714 and will be performed across multiple counties. Interested parties must submit their responses by December 21, 2026.

Department of Labor & Industries

POSTED

DEADLINE

in about 2 months

Cooperative Agreement for affiliated Partner with Great Basin Cooperative Ecosystem Studies Unit

Solicitation # G27AS00044

The U.S. Geological Survey is seeking a cooperative agreement partner through the Great Basin Cooperative Ecosystem Studies Unit to conduct research in species barcoding. The project focuses on enhancing aquatic species barcode libraries to support a pilot project in the Rocky Mountains that utilizes environmental DNA and metagenomics to monitor aquatic ecosystems. By combining metagenomics data with geospatial datasets, the initiative aims to develop artificial intelligence and machine-learning models capable of predicting community composition. The total estimated funding for this effort is 250,000 dollars for a two-year budget period, with one award expected. Applicants must be registered in SAM.gov and Grants.gov and submit their proposals via the Grants.gov portal by December 1, 2026. Evaluation is based on documentation completeness, basic eligibility, merit review by technical personnel, and budget reasonableness. Required submissions include a project narrative, detailed budget, and specific DOI forms for biographical sketches and current and pending support. Awardees must adhere to USGS Fundamental Science Practices and utilize the Department of the Treasury Automated Standard Application for Payments system for funding drawdowns. Key deliverables include a final technical report due 120 days after the performance period ends, along with annual financial reports and any required progress reports.

US Geological Survey

POSTED

DEADLINE

in about 1 month

Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Solicitation # RFA-RM-27-008

The National Institutes of Health, under the Department of Health and Human Services, is seeking applications for Genomic Data Generation Center(s) to support the Gabriella Miller Kids First Pediatric Research Program. The primary objective is the rapid production of high-quality sequence and variant data from human specimens related to pediatric conditions, specifically childhood cancers and congenital anomalies. Required data types include genome-wide, RNA, and long-read DNA and RNA sequencing, as well as chromatin accessibility data and genome-wide methylation profiling. All generated data will be re-processed and harmonized by the Kids First Pediatric Data Resource Center to maintain a public-facing, cloud-based resource for the research community. The NIH Common Fund intends to commit 5 to 6 million dollars annually for a maximum award period of three years, with an award ceiling of 3.5 million dollars. Applications are due by January 8, 2027, and will be evaluated via the NIH peer review system based on significance, investigator qualifications, innovation, and approach. A key requirement is the center's agility to implement new assays within a two-month timeframe. This opportunity is restricted to projects that do not propose clinical trials. Eligible applicants must maintain active registrations in SAM, eRA Commons, and Grants.gov. Awardees must adhere to strict cybersecurity protocols, including multifactor authentication and a 48-hour incident notification window, and comply with federal regulations 42 CFR Part 52 and 2 CFR Part 200. Proposals must include itemized per-sample costs, a minimum sample estimate, and a plan for cost reduction over the award period. All research involving human subjects must comply with 45 CFR Part 46, and a comprehensive Data Management and Sharing Plan is required at the time of application.

National Institutes Of Health

POSTED

DEADLINE

Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)

Solicitation # RFA-RM-27-009

This Single Source Notice of Funding Opportunity, solicitation RFA-RM-27-009, is issued by the National Institutes of Health to support the continued development of the Gabriella Miller Kids First Pediatric Data Resource Center. The initiative aims to accelerate the discovery of genetic etiologies and shared biologic pathways in childhood cancers and congenital anomalies through a cloud-based resource. This center integrates a Data Resource Core for data aggregation and analysis, a Data Coordination Core for harmonization and sharing, and an Administrative Core to manage operations and community outreach. Eligible organizations must submit applications by January 9, 2027, to be considered for this opportunity. All submissions will undergo a standard NIH peer-review process to ensure only meritorious applications are selected. The primary objective is to provide the broader scientific community with enhanced access to annotated genomic sequence and phenotypic data to advance pediatric research.

POSTED

DEADLINE

Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Solicitation # RFA-RM-27-008

The National Institutes of Health is seeking proposals under solicitation RFA-RM-27-008 to establish Genomic Data Generation Center(s) for the Gabriella Miller Kids First Pediatric Research Program. The primary objective is the rapid production of high-quality sequence and variant data from human specimens related to pediatric conditions, such as congenital anomalies and childhood cancers. This includes the generation of genome-wide, RNA, and long-read DNA and RNA sequencing, as well as chromatin accessibility data and genome-wide methylation profiling. All resulting data will be processed and harmonized by the Kids First Pediatric Data Resource Center to be hosted on a public-facing, cloud-based platform. This infrastructure is designed to allow the broader research community to search, analyze, and share annotated genomic and phenotypic datasets to foster collaboration in pediatric research. Interested parties must submit their responses by the deadline of January 9, 2027.

POSTED

DEADLINE

Health & Life Sciences Data ProviderThis subcontract opportunity with the Government of Canada seeks a Health and Life Sciences Data Provider to supply medical datasets and health-related information products. The selected provider will support prime contractors on Public Services and Procurement Canada projects by delivering pharmaceutical data, healthcare statistics, and clinical research information, as well as specialized life sciences reports. Interested parties must be capable of entering into a Provider’s Master License Agreement to facilitate the delivery of these datasets. The solicitation is open for responses until March 31, 2027, with the place of performance located within Canada.

Government of Canada / Gouvernement du Canada

POSTED

DEADLINE

Senior Advisor for Neurotherapeutic Network (Small Molecules)The Senior Advisor for Neurotherapeutic Network (Small Molecules) is a small business set-aside subcontract through the Department of Health and Human Services Omas Strategic Buying Center. The selected consultant will provide executive-level subject matter expertise to prime contractors supporting NIH NINDS Blueprint Neurotherapeutic Network projects. Primary responsibilities include reviewing program operations, offering strategic recommendations for pharmacology-related trials, and leading drug discovery teams focused on small molecules for nervous system conditions. Qualified candidates must possess a PhD in Pharmacology, an MD, or an advanced degree in Organic Chemistry. The role requires the delivery of high-level technical reports, detailed scientific analyses, and formal recommendations to meet project milestones. This opportunity was posted on October 28, 2026, with a response deadline of November 5, 2026, falling under NAICS code 541714.

Omas Strategic Buying Center - Professional Services

POSTED

DEADLINE

High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)

Solicitation # DARPA-PA-27-01

The High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE) program, solicited by the DARPA Biological Technologies Office under DARPA-PA-27-01, seeks to develop an in-silico capability for mapping all protein-protein interactions. The primary objective is to create a comprehensive human interactome hypercatalog capturing over 10 million new interactions, shifting from static biomarkers to dynamic, context-aware interactomes. The utility of this capability will be demonstrated by identifying novel diagnostic and therapeutic targets for traumatic brain injury. Awards will be issued as Other Transaction (OT) for Research agreements with fixed, payable milestones. The program is structured in two phases, with Phase 1 estimated at 12 months and Phase 2 anticipated at 18 months, though current awards are limited to Phase 1. Proposers, including large and small businesses, universities, and research institutions, must submit a maximum six-page unclassified abstract via the Broad Agency Announcement Tool by November 5, 2026, to be considered for an Oral Proposal Package due December 11, 2026. Evaluation is based on technical comprehension, technical ability, and the realism of the cost rough order of magnitude. Prime proposers must be registered in the System for Award Management and demonstrate CMMC Level 1 compliance. Performance will be managed through a Task Description Document and a milestone-based payment schedule, with invoicing processed through the Wide Area Workflow system. Security requirements include the Fundamental Research Risk-Based Security Review Process for all senior and key personnel.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Pharmacology and Pain Drug Development SMEThis subcontract opportunity through the Department of Health and Human Services Omas Strategic Buying Center seeks a subject matter expert in pharmacology and pain to support prime contractors on NIH HEAL Initiative projects. The selected expert will provide executive-level guidance on small molecule and biologic therapeutics, focusing on drug discovery and pharmacology-related trials for nervous system conditions. Key responsibilities include performing strategic programmatic reviews, evaluating milestones, and providing mentorship. The role requires the delivery of strategic recommendations and milestone evaluations through formal committee reports. Performance will take place in Bethesda, and the opportunity is categorized under NAICS code 541714. Interested parties should note the response deadline of November 3, 2026.

Omas Strategic Buying Center - Professional Services

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS